DAY 1 Session 1: Epidemiology of drug and toxin-induced pulmonary hypertension

views comments

WSPH and ESC/ERS guidelines:
New classification of PH risk factor
Gérald Simonneau (Paris-Saclay)

Pharmacovigilance: Capturing a rare-disease signal
Qun-Ying Yue (Uppsala Monitoring Centre, UMC)

Identifying new drugs associated with PAH
Charles Khouri (Grenoble)